Results 31 to 40 of about 368,846 (181)

Antigenic and biochemical characterization of bovine rotavirus V1005, a new member of rotavirus serotype 10 [PDF]

, 1990
Bovine rotavirus (BRV) V1005 is serologically distinct from rotavirus serotypes 1, 2, 3, 4, 5, 6, 8 and 9. BRV V1005 showed cross-reactions with BRV B223, the American prototype of serotype 10 rotavirus, and with BRV E4049, a British serotype 10 isolate.
Bruttin, Anne, Fitzgerald, Tracey, Eichhorn, Werner, Snodgrass, David, Büssow, Harald, Gerhards, Roswitha   +5 more
core   +1 more source

Global rotavirus vaccine introductions and coverage: 2006 – 2016

Human Vaccines & Immunotherapeutics, 2018
An estimated 215,000 children died of rotavirus infections in 2013, accounting for 37% of diarrhea-related deaths worldwide, 92% of which occurred in low and lower-middle income countries. Since 2009 the World Health Organization (WHO) recommends the use
Alice J. Abou-Nader, Molly A. Sauer, A. Duncan Steele, Jacqueline E. Tate, Deborah Atherly, Umesh D. Parashar, Mathuram Santosham, E. Anthony S. Nelson   +7 more
doaj   +1 more source

Cattle develop neutralizing antibodies to rotavirus serotypes which could not be isolated from faeces of symptomatic calves [PDF]

, 1991
Neutralizing antibodies against 10 serotypes of rotavirus were measured in sera from different age groups of German cattle. Only five of 143 sera did not neutralize heterologous serotypes.
Sidoti, Josette, Eichhorn, Werner, Snodgrass, David, Büssow, Harald, Rohwedder, Angela   +4 more
core   +1 more source

Characterization of Rotavirus Infection in Hospitalized Children under 5 with Acute Gastroenteritis 5 Years after Introducing the Rotavirus Vaccines in South Korea

Children, 2022
We herein characterized rotavirus infection in hospitalized children under 5 years of age with gastroenteritis after introducing rotavirus vaccines in South Korea from 20 February 2012, to 31 March 2013.
Hye Sun Yoon, Yong-Hak Sohn, Jeong Don Chae, Jiseun Lim, Seung Yeon Kim   +4 more
doaj   +1 more source

Isolation of an Avianlike Group A Rotavirus from a Calf with Diarrhea [PDF]

, 1992
An atypical group A rotavirus (993/83) was isolated from a 3-day-old German calf with diarrhea. It differed from 35 conventional German bovine rotavirus isolates analyzed previously with respect to subgroup (strain 993/83 was non-subgroup I and non ...
Gerna, Giuseppe, Eichhorn, Werner, Nakagomi, Osamu, Büssow, Harald   +3 more
core   +1 more source

Measurement of coverage, compliance and determinants of uptake in a publicly funded rotavirus vaccination programme: a retrospective cohort study

BMJ Open, 2019
Objectives In June 2015, Alberta, Canada instituted a universal publicly funded rotavirus vaccination programme (Rotarix, RV1), with vaccine doses scheduled for 2 and 4 months of age.
Lawrence W Svenson, Ellen Rafferty, Xiaoyan Guo, Bruce McDonald, Shannon Elizabeth MacDonald   +4 more
doaj   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network

The Lancet Global Health, 2019
Summary: Background: Rotavirus vaccine use in national immunisation programmes has led to declines in hospital admissions for rotavirus gastroenteritis among children; however, the global impact of rotavirus vaccine introduction has not been described ...
Negar Aliabadi, MD, Sébastien Antoni, MPH, Jason M Mwenda, PhD, Goitom Weldegebriel, MD, Joseph N M Biey, MD, Dah Cheikh, MD, Kamal Fahmy, MD, Nadia Teleb, MD, Hossam Abdelrahman Ashmony, BSc, Hinda Ahmed, PhD, Danni S Daniels, MS, Dovile Videbaek, MD, Annemarie Wasley, ScD, Simarjit Singh, MSc(IT), Lucia Helena de Oliveira, PhD, Gloria Rey-Benito, MSc, N Jennifer Sanwogou, MPH, Pushpa Ranjan Wijesinghe, MD, Jayantha B L Liyanage, MD, Batmunkh Nyambat, MD, Varja Grabovac, MSc, James D Heffelfinger, MD, Kimberley Fox, MD, Fem Julia Paladin, PhD, Tomoka Nakamura, MSPH, Mary Agócs, MD, Jillian Murray, MSPH, Thomas Cherian, MD, Catherine Yen, MD, Umesh D Parashar, MBBS, Fatima Serhan, PhD, Jacqueline E Tate, PhD, Adam L Cohen, MD   +32 more
doaj   +1 more source

Trends in hospitalizations for vaccine‐preventable diseases in the United States from 2014 to 2024

Journal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Vaccination rates have declined in recent years, resulting in outbreaks of vaccine‐preventable diseases (VPDs) among children. We aimed to evaluate VPD hospitalization rates from 2014 to 2024 and to report associated trends in outcomes including intensive care utilization, mortality, readmissions, and costs.
Nathan M. Money, Erin Sullivan, Hannah Rector, Corrie E. McDaniel, Jessica L. Markham, Mersine A. Bryan   +5 more
wiley   +1 more source

PROTECTIVE ACTIVITY STUDY OF A CANDIDATE VACCINE AGAINST ROTAVIRUS INFECTION BASED ON RECOMBINANT PROTEIN FliCVP6VP8

Медицинская иммунология, 2016
Rotavirus infection is among leading causes of severe diarrhea which often leads to severe dehydration, especially, in children under 5 years old. In Russia, the incidence of rotavirus infection is constantly increased, due to higher rates of actual ...
I. V. Dukhovlinov, E. G. Bogomolova, E. A. Fedorova, A. S. Simbirtsev   +3 more
doaj   +1 more source